Effect of glutamine in patients with esophagus resection

S. Marton, S. Ghosh, A. Papp, L. Bogár, T. Kőszegi, V. Juhasz, L. Cseke, O. Horvath

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Glutamine is the most abundant amino-acid in the extra- and intracellular compartments of the human body, which accounts for over 50% of its free amino-acid content. Utilization of glutamine peptides is explicitly useful, resulting in a decrease in the number of postoperative infectious complications, period of hospitalization, and therapeutic costs. This article aims to study the effects of glutamine on systemic inflammatory response, morbidity, and mortality after esophagectomy. A prospective, randomized, double-blind, and controlled trial was used. Following sealed-envelope block randomization, the patients were divided into two groups. Members of the glutamine group (group G) received glutamine (Dipeptiven, Fresenius) as continuous infusion for 6 hours at 0.5 g/kg for 3 days prior to, and 7 days following surgery; while patients of the control group were given placebo. We examined 30 patients in group G, and 25 patients as controls. In both patient groups, the levels of total protein, albumin, pre-albumin, retinol binding protein, transferrin, transferring-saturation, C-reactive protein, procalcitonin, lymphocte, Interleukin-6, Interleukin-8, tumor necrosis factor alpha, and serum lactate were determined prior to surgery (t0), directly after surgery (tu), following surgery on day 1 (t1), day 2 (t2), and day 7 (t7). For statistical analysis Mann-Whitney U test and chi-square test were used. There was no significant difference between the two groups regarding age, male/female ratio, and SAPS II scores. Intensive care unit morbidity and mortality was similar in both groups (group G: 24 survivors/6 nonsurvivors; Control: 17 survivors/8 nonsurvivors; P = 0.607). Daily Multiple Organ Dysfunction Score did not differ significantly between the two groups. The observed inflammatory markers followed the pattern we described without significant difference. Based on our study, the glutamine supplementation that we used had no influence on morbidity, mortality, or postoperative inflammatory response after esophagectomy.

Original languageEnglish
Pages (from-to)106-111
Number of pages6
JournalDiseases of the Esophagus
Volume23
Issue number2
DOIs
Publication statusPublished - 2010

Fingerprint

Glutamine
Esophagus
Esophagectomy
Morbidity
Ambulatory Surgical Procedures
alanylglutamine
Survivors
Mortality
Albumins
Organ Dysfunction Scores
Amino Acids
Retinol-Binding Proteins
Calcitonin
Chi-Square Distribution
Transferrin
Random Allocation
Nonparametric Statistics
Interleukin-8
Human Body
C-Reactive Protein

Keywords

  • Esophagectomy
  • Glutamine
  • Microalbuminuria
  • Procalcitonin
  • Systemic inflammatory response

ASJC Scopus subject areas

  • Gastroenterology
  • Medicine(all)

Cite this

Effect of glutamine in patients with esophagus resection. / Marton, S.; Ghosh, S.; Papp, A.; Bogár, L.; Kőszegi, T.; Juhasz, V.; Cseke, L.; Horvath, O.

In: Diseases of the Esophagus, Vol. 23, No. 2, 2010, p. 106-111.

Research output: Contribution to journalArticle

Marton, S. ; Ghosh, S. ; Papp, A. ; Bogár, L. ; Kőszegi, T. ; Juhasz, V. ; Cseke, L. ; Horvath, O. / Effect of glutamine in patients with esophagus resection. In: Diseases of the Esophagus. 2010 ; Vol. 23, No. 2. pp. 106-111.
@article{f412037081a746a7822c52dcfc955fa4,
title = "Effect of glutamine in patients with esophagus resection",
abstract = "Glutamine is the most abundant amino-acid in the extra- and intracellular compartments of the human body, which accounts for over 50{\%} of its free amino-acid content. Utilization of glutamine peptides is explicitly useful, resulting in a decrease in the number of postoperative infectious complications, period of hospitalization, and therapeutic costs. This article aims to study the effects of glutamine on systemic inflammatory response, morbidity, and mortality after esophagectomy. A prospective, randomized, double-blind, and controlled trial was used. Following sealed-envelope block randomization, the patients were divided into two groups. Members of the glutamine group (group G) received glutamine (Dipeptiven, Fresenius) as continuous infusion for 6 hours at 0.5 g/kg for 3 days prior to, and 7 days following surgery; while patients of the control group were given placebo. We examined 30 patients in group G, and 25 patients as controls. In both patient groups, the levels of total protein, albumin, pre-albumin, retinol binding protein, transferrin, transferring-saturation, C-reactive protein, procalcitonin, lymphocte, Interleukin-6, Interleukin-8, tumor necrosis factor alpha, and serum lactate were determined prior to surgery (t0), directly after surgery (tu), following surgery on day 1 (t1), day 2 (t2), and day 7 (t7). For statistical analysis Mann-Whitney U test and chi-square test were used. There was no significant difference between the two groups regarding age, male/female ratio, and SAPS II scores. Intensive care unit morbidity and mortality was similar in both groups (group G: 24 survivors/6 nonsurvivors; Control: 17 survivors/8 nonsurvivors; P = 0.607). Daily Multiple Organ Dysfunction Score did not differ significantly between the two groups. The observed inflammatory markers followed the pattern we described without significant difference. Based on our study, the glutamine supplementation that we used had no influence on morbidity, mortality, or postoperative inflammatory response after esophagectomy.",
keywords = "Esophagectomy, Glutamine, Microalbuminuria, Procalcitonin, Systemic inflammatory response",
author = "S. Marton and S. Ghosh and A. Papp and L. Bog{\'a}r and T. Kőszegi and V. Juhasz and L. Cseke and O. Horvath",
year = "2010",
doi = "10.1111/j.1442-2050.2009.01007.x",
language = "English",
volume = "23",
pages = "106--111",
journal = "Diseases of the Esophagus",
issn = "1120-8694",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Effect of glutamine in patients with esophagus resection

AU - Marton, S.

AU - Ghosh, S.

AU - Papp, A.

AU - Bogár, L.

AU - Kőszegi, T.

AU - Juhasz, V.

AU - Cseke, L.

AU - Horvath, O.

PY - 2010

Y1 - 2010

N2 - Glutamine is the most abundant amino-acid in the extra- and intracellular compartments of the human body, which accounts for over 50% of its free amino-acid content. Utilization of glutamine peptides is explicitly useful, resulting in a decrease in the number of postoperative infectious complications, period of hospitalization, and therapeutic costs. This article aims to study the effects of glutamine on systemic inflammatory response, morbidity, and mortality after esophagectomy. A prospective, randomized, double-blind, and controlled trial was used. Following sealed-envelope block randomization, the patients were divided into two groups. Members of the glutamine group (group G) received glutamine (Dipeptiven, Fresenius) as continuous infusion for 6 hours at 0.5 g/kg for 3 days prior to, and 7 days following surgery; while patients of the control group were given placebo. We examined 30 patients in group G, and 25 patients as controls. In both patient groups, the levels of total protein, albumin, pre-albumin, retinol binding protein, transferrin, transferring-saturation, C-reactive protein, procalcitonin, lymphocte, Interleukin-6, Interleukin-8, tumor necrosis factor alpha, and serum lactate were determined prior to surgery (t0), directly after surgery (tu), following surgery on day 1 (t1), day 2 (t2), and day 7 (t7). For statistical analysis Mann-Whitney U test and chi-square test were used. There was no significant difference between the two groups regarding age, male/female ratio, and SAPS II scores. Intensive care unit morbidity and mortality was similar in both groups (group G: 24 survivors/6 nonsurvivors; Control: 17 survivors/8 nonsurvivors; P = 0.607). Daily Multiple Organ Dysfunction Score did not differ significantly between the two groups. The observed inflammatory markers followed the pattern we described without significant difference. Based on our study, the glutamine supplementation that we used had no influence on morbidity, mortality, or postoperative inflammatory response after esophagectomy.

AB - Glutamine is the most abundant amino-acid in the extra- and intracellular compartments of the human body, which accounts for over 50% of its free amino-acid content. Utilization of glutamine peptides is explicitly useful, resulting in a decrease in the number of postoperative infectious complications, period of hospitalization, and therapeutic costs. This article aims to study the effects of glutamine on systemic inflammatory response, morbidity, and mortality after esophagectomy. A prospective, randomized, double-blind, and controlled trial was used. Following sealed-envelope block randomization, the patients were divided into two groups. Members of the glutamine group (group G) received glutamine (Dipeptiven, Fresenius) as continuous infusion for 6 hours at 0.5 g/kg for 3 days prior to, and 7 days following surgery; while patients of the control group were given placebo. We examined 30 patients in group G, and 25 patients as controls. In both patient groups, the levels of total protein, albumin, pre-albumin, retinol binding protein, transferrin, transferring-saturation, C-reactive protein, procalcitonin, lymphocte, Interleukin-6, Interleukin-8, tumor necrosis factor alpha, and serum lactate were determined prior to surgery (t0), directly after surgery (tu), following surgery on day 1 (t1), day 2 (t2), and day 7 (t7). For statistical analysis Mann-Whitney U test and chi-square test were used. There was no significant difference between the two groups regarding age, male/female ratio, and SAPS II scores. Intensive care unit morbidity and mortality was similar in both groups (group G: 24 survivors/6 nonsurvivors; Control: 17 survivors/8 nonsurvivors; P = 0.607). Daily Multiple Organ Dysfunction Score did not differ significantly between the two groups. The observed inflammatory markers followed the pattern we described without significant difference. Based on our study, the glutamine supplementation that we used had no influence on morbidity, mortality, or postoperative inflammatory response after esophagectomy.

KW - Esophagectomy

KW - Glutamine

KW - Microalbuminuria

KW - Procalcitonin

KW - Systemic inflammatory response

UR - http://www.scopus.com/inward/record.url?scp=77953155301&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953155301&partnerID=8YFLogxK

U2 - 10.1111/j.1442-2050.2009.01007.x

DO - 10.1111/j.1442-2050.2009.01007.x

M3 - Article

VL - 23

SP - 106

EP - 111

JO - Diseases of the Esophagus

JF - Diseases of the Esophagus

SN - 1120-8694

IS - 2

ER -